For a patient whose thyroid‑stimulating hormone (TSH) is overly suppressed on levothyroxine 112 µg daily and remains elevated on 100 µg daily, is it preferable to alternate doses or to skip the 112 µg dose 1–2 days per week?

Alternating Daily Doses is the Preferred Strategy

For a patient whose TSH is overly suppressed on 112 mcg and undertreated on 100 mcg levothyroxine, alternating between these two doses daily (e.g., 100 mcg one day, 112 mcg the next) is the better approach compared to skipping doses 1-2 days per week. This provides more consistent weekly hormone delivery and avoids the physiologic disruption of intermittent dosing gaps.

Rationale Based on Guidelines and Pharmacology

The AACE/ATA guidelines emphasize that daily dosing of levothyroxine is ideal 1. While the guidelines acknowledge that missed doses should be made up when recognized, they explicitly state this is for compliance problems—not as a planned dosing strategy 1. The long half-life of levothyroxine (approximately 7 days) means that alternating daily doses creates a stable average weekly dose without the peaks and troughs associated with skipping days.

Why Alternating is Superior

• Consistent weekly exposure: Alternating 100 mcg and 112 mcg provides an average of 106 mcg daily (742 mcg/week), delivering steady hormone levels
• Avoids physiologic gaps: Skipping 1-2 days creates periods of relative hormone deficiency, potentially causing symptom fluctuation
• Supported by dose adjustment principles: The FDA label and guidelines recommend dose adjustments in 12.5-25 mcg increments 2. Alternating these two doses effectively creates a 6 mcg daily increment—a finer titration than standard adjustments allow
• Better compliance: Daily medication-taking maintains the habit; skipping days may lead to confusion and true non-adherence

Practical Implementation

Specific dosing schedule: Have the patient alternate 100 mcg and 112 mcg every other day (Monday/Wednesday/Friday/Sunday one dose, Tuesday/Thursday/Saturday the other). Use a pill organizer to prevent confusion.

Monitoring timeline: Check TSH in 4-8 weeks after initiating this regimen 1, 2. The guidelines specify that dose adjustments require 4-8 weeks for TSH to plateau, particularly with smaller dose changes 1.

Target TSH: Aim for TSH within the normal reference range (typically 0.4-4.0 mIU/L), avoiding both suppression (which increases cardiovascular and skeletal risks) 1 and elevation (indicating undertreatment).

Important Caveats

When Skipping Might Be Considered

The only scenario where planned dose-skipping has evidence support is for severe compliance problems, where weekly dosing has been studied 1, 3. However, research shows weekly dosing results in higher TSH levels (1.14-1.78 mIU/L higher) compared to daily dosing, though still within reference range 4, 3. This is not your patient's situation—they need fine-tuning between two close doses, not a compliance intervention.

Risk of Overtreatment

Be vigilant about TSH suppression. The guidelines warn that 20% of patients on thyroid hormone are overtreated 1, with consequences including:

• Atrial fibrillation (especially in elderly patients)
• Accelerated bone loss (particularly in postmenopausal women)
• Cardiovascular complications 1

If alternating doses still results in suppressed TSH, consider that the patient may need less than 100 mcg daily—perhaps alternating 100 mcg with 88 mcg, or switching to a consistent lower dose.

Factors That May Affect Dosing

Before finalizing this approach, verify:

• Medication interactions: Proton pump inhibitors, calcium, iron, and other medications can impair absorption 1
• Timing of administration: Levothyroxine should be taken 30-60 minutes before breakfast on an empty stomach 1, 2
• True compliance: Patients on high doses with elevated TSH are often non-compliant rather than malabsorbing 1
• Weight changes: Dose requirements decrease with weight loss and aging 1

Alternative: Custom Compounding

If alternating proves confusing for the patient, some pharmacies can compound a custom dose (e.g., 106 mcg), though this is rarely necessary and the FDA-approved tablet formulations are preferred for consistency 2.

Bottom line: Alternating 100 mcg and 112 mcg daily provides the most physiologically sound approach to fine-tune this patient's dose, maintaining daily dosing habits while achieving an intermediate weekly exposure that should normalize TSH without suppression 1, 2.